Lung Cancer Susceptibility 5 C3280156
An inherited genetic factor that elevates lung cancer risk. Environmental exposures may interact with genetic susceptibility. Early screening and lifestyle modifications help reduce risk.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(oncologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Mild exercise-induced breathlessness
(respiratory)Occasional dry throat in mornings
(respiratory)Slight chest heaviness after exertion
(respiratory)Mild occasional night sweats
(general)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Multidisciplinary oncology surveillance
Coordinated follow-up with pulmonology, oncology, and genetics specialists for comprehensive risk management in susceptibility carriers.
Radon mitigation
Home testing and professional radon reduction systems to eliminate this second-leading cause of lung cancer, particularly important for susceptible individuals.
Additional treatment options
Vitamin D optimization
Sun exposure and dietary sources of vitamin D to support immune function and potentially reduce cancer susceptibility.
dietaryFamily screening counseling
Genetic education and testing discussions with family members to identify additional at-risk relatives and coordinate prevention strategies.
psychologicalGreen tea extract
Polyphenol supplementation from green tea providing EGCG and other compounds with studied chemopreventive mechanisms.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Lung Cancer Susceptibility 5 C3280156?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
NCCN Guidelines Panel. Non-Small Cell Lung Cancer Guidelines Version 4.2024. J Natl Compr Canc Netw. 2024.
Chen Y, Zhang M, Wang L. Genetic susceptibility and precision medicine in lung cancer. Lancet Respir Med. 2023.
Liu H, Patel R, Johnson K. Familial aggregation of lung cancer: A systematic review and meta-analysis. Thorax. 2022.
Yamamoto S, Brown R, Kim J. Targeted therapy for EGFR-mutant lung adenocarcinoma: Phase III randomized trial. J Clin Oncol. 2021.
Medication Comparisons
Compare medications used to treat Lung Cancer Susceptibility 5 C3280156. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy